Advertisement

HindustanTimes Sun,21 Sep 2014

Sun Pharma acquires US-based Pharmalucence

PTI  New Delhi, July 16, 2014
First Published: 11:11 IST(16/7/2014) | Last Updated: 13:26 IST(16/7/2014)

Drug major Sun Pharmaceutical Industries has acquired US-based Pharmalucence Inc for an undisclosed amount.

Advertisement

Pharmalucence, which has sterile injectable capacity in the US, has been acquired by one of the subsidiaries of Sun Pharma, the Mumbai-based firm said in a statement on Wednesday.

The company, however, did not disclose the financial details of the deal.

Earlier this year, Sun Pharma had acquired Ranbaxy Laboratories in an all-stock transaction with a total equity value of USD 3.2 billion along with debt of USD 800 million, taking the overall deal value to USD 4 billion.

Sun Pharma shares were trading at Rs. 748.30, up 1.30% from its previous close.


Advertisement
more from Business

Airlines oppose govt policy on connectivity to remote areas

Airlines and private charter operators have opposed the government's draft policy on air connectivity to regional and remote areas, saying it will have severe impact on their financial strength.
markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved